Molecular Biologic Assessment of Cutaneous Specimens of Ocular Rosacea

被引:23
作者
Wladis, Edward J. [1 ]
Iglesias, Bibiana V. [2 ]
Adam, Alejandro P. [3 ]
Gosselin, Edmund J. [2 ]
机构
[1] Albany Med Coll, Dept Ophthalmol, New York, NY USA
[2] Albany Med Coll, Div Immunol & Microbial Dis, New York, NY USA
[3] Albany Med Coll, Ctr Cell Biol & Canc Res, New York, NY USA
关键词
SKIN; EXPRESSION; IL-1-BETA; THERAPY; CELLS; INTERLEUKIN-16; ENDOTHELIUM; DERMATITIS; MIG/CXCL9; DISEASE;
D O I
10.1097/IOP.0b013e31824dd9d4
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To characterize the molecular biologic environment of pathological skin in ocular rosacea and to differentiate the levels of inflammatory molecules in ocular rosacea from those of normal skin. Methods: The concentrations of 48 molecules were assayed in cutaneous biopsies taken from patients with ocular rosacea and from normal controls. Results: There were very few molecular differences between the 2 groups, and 43 of the 48 molecules that were measured in this study were not significantly different between the 2 groups. The concentrations of 5 molecules (interleukin-1 beta, interleukin-16, stem cell factor, monocyte chemotactic protein-1, and monokine induced by gamma-interferon) were significantly enriched in ocular rosacea. Conclusions: Ocular rosacea is a highly ordered molecular process and involves elevations in the concentrations of specific molecules. The particular pattern of enrichment supports the notion that ocular rosacea represents a disorder of innate immunity. Furthermore, these molecules may represent novel therapeutic targets in the future management of this disorder. (Ophthal Plast Reconstr Surg 2012;28:246-250)
引用
收藏
页码:246 / 250
页数:5
相关论文
共 32 条
[1]  
Abu El-Asrar AM, 2010, MOL VIS, V16, P1098
[2]  
Afonso AA, 1999, INVEST OPHTH VIS SCI, V40, P2506
[3]  
Akpek EK, 1997, OPHTHALMOLOGY, V104, P1863, DOI 10.1016/S0161-6420(97)30015-3
[4]   Inflammatory cytokines in the tears of patients with ocular rosacea [J].
Barton, K ;
Monroy, DC ;
Nava, A ;
Pflugfelder, SC .
OPHTHALMOLOGY, 1997, 104 (11) :1868-1874
[5]   Relaxin inhibits early steps in vascular inflammation [J].
Brecht, Anna ;
Bartsch, Cornelia ;
Baumann, Gert ;
Stangl, Karl ;
Dschietzig, Thomas .
REGULATORY PEPTIDES, 2011, 166 (1-3) :76-82
[6]  
Church LD, 2009, CURR OPIN MOL THER, V11, P81
[7]   INTERLEUKIN-1 IN HUMAN SKIN - DYSREGULATION IN PSORIASIS [J].
COOPER, KD ;
HAMMERBERG, C ;
BAADSGAARD, O ;
ELDER, JT ;
CHAN, LS ;
TAYLOR, RS ;
VOORHEES, JJ ;
FISHER, G .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1990, 95 (05) :S24-S26
[8]   C-KIT, by interacting with the membrane-bound ligand, recruits endothelial progenitor cells to inflamed endothelium [J].
Dentelli, Patrizia ;
Rosso, Arturo ;
Balsamo, Antonina ;
Benedetto, Sofia Colmenares ;
Zeoli, Annarita ;
Pegoraro, Marco ;
Camussi, Giovanni ;
Pegoraro, Luigi ;
Brizzi, Maria Felice .
BLOOD, 2007, 109 (10) :4264-4271
[9]   Interleukin-1 in the pathogenesis and treatment of inflammatory diseases [J].
Dinarello, Charles A. .
BLOOD, 2011, 117 (14) :3720-3732
[10]   The CXC chemokine MIG/CXCL9 is important in innate immunity against Streptococcus pyogenes [J].
Egesten, Arne ;
Eliasson, Mette ;
Johansson, Helena M. ;
Olin, Anders I. ;
Morgelin, Matthias ;
Mueller, Anja ;
Pease, James E. ;
Frick, Inga-Maria ;
Bjorck, Lars .
JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (05) :684-693